Accelerate to discover

Homepage>Discover>A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy

Back to filter

Apr 10, 2019

Layer-by-layer assembly techniques have been extensively studied in cell biology because of their simplicity of...

Product update: The high pass plus cassette

Apr 9, 2019

The high pass plus gel cassette is the newest addition to the Pippin family. It is dedicated to the BluePippin...

Comprehending diseased cardiac mechanics using speckle tracking echocardiography

Apr 4, 2019

Are you working with high ultrasound imaging and are you interesting in speckle tracking echocardiography (STE)? Watch...

Novel imaging-based assay for hERG channel inhibition using iPS-derived Cardiomyocytes

Apr 4, 2019

A large percentage of drugs fail in clinical studies due to cardiac toxicity, such as drug-induced QT...

Apr 20, 2019

Modified Beta-carotene-bound albumin nanoparticles for breast tumor ablation

Mar 29, 2019

The albumin nanoparticles were fabricated using a beta-carotene cross-linker via the Nab technique. These new albumin...

Spectral flow cytometric analysis of loss-of-function mutations in granular cell tumors

Mar 29, 2019

Granular cell tumors (GCTs) are rare tumors that can arise in multiple anatomical locations,and are characterized by...

IncuCyte white paper: live-cell analysis for Neuroscientists

Mar 20, 2019

Stem cell technologies using iPSCs allow researchers to create differentiated neurons and support cells to study human...

Apr 20, 2019

Cell plasticity associated to circulating tumor cells from prostate cancer patients

Mar 13, 2019

Treatment resistance is associated with tumor cells molecular plasticity. In metastatic castration resistant prostate...

Show all topics (10)

A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy

Sep 18, 2018

Antigen-specific cytotoxic T lymphocytes (CTLs), which eliminate target cells bearing antigenic peptides presented by surface major histocompatibility complex (MHC) class I molecules, play a key role in cancer immunotherapy. However, the majority of tumors are not immunologically rejected since they express self-antigens which are not recognized by CTLs as foreign. To foreignize these tumors for CTL-mediated immunological rejection, it is essential to develop carriers that can effectively deliver foreign antigens to cancer cells.

Do you want to learn more? Read this interesting article!

Scientific paper

Application

Get more info